West Pharmaceutical Services Total Liabilities and Share Holders Equity 2010-2024 | WST

West Pharmaceutical Services total liabilities and share holders equity from 2010 to 2024. Total liabilities and share holders equity can be defined as the total of all liabilities and shareholders' equity.
  • West Pharmaceutical Services total liabilities and share holders equity for the quarter ending September 30, 2024 was $3.675B, a 2.12% decline year-over-year.
  • West Pharmaceutical Services total liabilities and share holders equity for 2023 was $3.83B, a 5.88% increase from 2022.
  • West Pharmaceutical Services total liabilities and share holders equity for 2022 was $3.617B, a 9.14% increase from 2021.
  • West Pharmaceutical Services total liabilities and share holders equity for 2021 was $3.314B, a 18.61% increase from 2020.
West Pharmaceutical Services Annual Total Liabilities and Share Holders Equity
(Millions of US $)
2023 $3,830
2022 $3,617
2021 $3,314
2020 $2,794
2019 $2,341
2018 $1,979
2017 $1,863
2016 $1,717
2015 $1,695
2014 $1,670
2013 $1,672
2012 $1,564
2011 $1,399
2010 $1,294
2009 $1,271
West Pharmaceutical Services Quarterly Total Liabilities and Share Holders Equity
(Millions of US $)
2024-09-30 $3,675
2024-06-30 $3,489
2024-03-31 $3,602
2023-12-31 $3,830
2023-09-30 $3,755
2023-06-30 $3,670
2023-03-31 $3,724
2022-12-31 $3,617
2022-09-30 $3,317
2022-06-30 $3,362
2022-03-31 $3,295
2021-12-31 $3,314
2021-09-30 $3,143
2021-06-30 $2,934
2021-03-31 $2,740
2020-12-31 $2,794
2020-09-30 $2,583
2020-06-30 $2,392
2020-03-31 $2,247
2019-12-31 $2,341
2019-09-30 $2,174
2019-06-30 $2,123
2019-03-31 $2,036
2018-12-31 $1,979
2018-09-30 $1,946
2018-06-30 $1,874
2018-03-31 $1,870
2017-12-31 $1,863
2017-09-30 $1,930
2017-06-30 $1,843
2017-03-31 $1,734
2016-12-31 $1,717
2016-09-30 $1,735
2016-06-30 $1,705
2016-03-31 $1,668
2015-12-31 $1,695
2015-09-30 $1,667
2015-06-30 $1,664
2015-03-31 $1,596
2014-12-31 $1,670
2014-09-30 $1,673
2014-06-30 $1,705
2014-03-31 $1,708
2013-12-31 $1,672
2013-09-30 $1,665
2013-06-30 $1,613
2013-03-31 $1,577
2012-12-31 $1,564
2012-09-30 $1,527
2012-06-30 $1,463
2012-03-31 $1,457
2011-12-31 $1,399
2011-09-30 $1,398
2011-06-30 $1,415
2011-03-31 $1,366
2010-12-31 $1,294
2010-09-30 $1,300
2010-06-30 $1,222
2010-03-31 $1,254
2009-12-31 $1,271
2009-09-30 $1,264
2009-06-30 $1,218
2009-03-31 $1,142
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $23.723B $2.950B
West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $78.143B 21.32
Becton Dickinson (BDX) United States $67.812B 17.83
Cardinal Health (CAH) United States $29.438B 15.96
Cooper (COO) United States $20.623B 29.35
Labcorp (LH) United States $20.401B 16.92
Align Technology (ALGN) United States $16.815B 32.18
Henry Schein (HSIC) United States $8.514B 16.22
Merit Medical Systems (MMSI) United States $6.067B 30.98
DENTSPLY SIRONA (XRAY) United States $3.508B 9.54
CONMED (CNMD) United States $2.312B 19.29
Patterson (PDCO) United States $1.855B 9.79
STAAR Surgical (STAA) United States $1.499B 55.31
Lifevantage (LFVN) United States $0.176B 23.40
Pro-Dex (PDEX) United States $0.154B 30.74